5Daniel DG, Zimbroff DL, Swift RH, et al. The tolera- bility of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy [J]. Int Clin Psychophar- macol,2004, 19 (1):5.
6Zhang H, Wang G, Zhao J, et ai. Intramuscular zi- prasidone versus haloperidol for managing agitation in Chi- nese patients with schizophrenia [J]. J Clin Psychopharma- eol,2013,33(2) : 178.